Vinblastine
Showing 1 - 25 of 281
Classical Hodgkin Lymphoma Trial in Seattle (drug, other, biological)
Recruiting
- Classical Hodgkin Lymphoma
- Dacarbazine
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2022
Grade 1 Glioma, Mixed Glio-neuronal Tumors, Pleomorphic Xanthoastrocytoma Trial in Strasbourg (Trametinib, Vinblastine)
Recruiting
- Grade 1 Glioma
- +2 more
- Trametinib
- Vinblastine
-
Strasbourg, FranceCHU Strasbourg - France
Jul 7, 2022
AML, Hyperleukocytosis Trial in Monterrey (Vinblastine, Hydroxyurea capsules)
Recruiting
- AML
- Hyperleukocytosis
- Vinblastine
- Hydroxyurea capsules
-
Monterrey, Nuevo Leon, MexicoHopsital Universitario Dr. Jose E. Gonzalez, Centro Universitari
Oct 9, 2021
Hodgkin Disease Trial in Worldwide (Brentuximab vedotin, Doxorubicin, Vinblastine)
Completed
- Hodgkin Disease
- Brentuximab vedotin
- +3 more
-
Aurora, Colorado
- +13 more
Jun 17, 2022
Classical Hodgkin Lymphoma Trial in Cologne (Nivolumab, Adriamycin, Vinblastine)
Active, not recruiting
- Classical Hodgkin Lymphoma
- Nivolumab
- +3 more
-
Cologne, GermanyUniversity Hospital of Cologne
Aug 5, 2022
Classical Hodgkin Lymphoma Trial in Charlottesville (Pembrolizumab, Doxorubicin, Vinblastine)
Recruiting
- Classical Hodgkin Lymphoma
- Pembrolizumab
- +4 more
-
Charlottesville, VirginiaUniversity of Virginia
Jul 27, 2022
Urothelial Carcinoma of the Bladder Trial in Washington, Baltimore, Philadelphia (drug, radiation, procedure)
Active, not recruiting
- Urothelial Carcinoma of the Bladder
- Methotrexate
- +7 more
-
Washington, District of Columbia
- +3 more
Dec 2, 2022
Bladder Adenocarcinoma, Bladder Mixed Adenocarcinoma, Bladder Squamous Cell Carcinoma Trial in Palo Alto (drug, procedure,
Active, not recruiting
- Bladder Adenocarcinoma
- +11 more
- Carboplatin
- +7 more
-
Palo Alto, CaliforniaStanford Cancer Institute Palo Alto
Mar 25, 2022
Langerhans Cell Histiocytosis Trial in United States (Cytarabine, Vinblastine/prednisone)
Recruiting
- Langerhans Cell Histiocytosis
-
San Diego, California
- +4 more
Jun 2, 2021
HIV Infection, HIV-associated Hodgkin Lymphoma, Stage III Adult Hodgkin Lymphoma Trial in France (brentuximab vedotin,
Active, not recruiting
- HIV Infection
- +3 more
- brentuximab vedotin
- +3 more
-
Clamart, France
- +5 more
Aug 11, 2022
Urothelial Carcinoma, Bladder Cancer Trial in Houston (Abiraterone acetate, Durvalumab, Methotrexate)
Recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Abiraterone acetate
- +5 more
-
Houston, TexasM D Anderson Cancer Center
Jun 2, 2022
Childhood Solid Tumor Trial in Belgium, France (Vinblastine, Cyclophosphamide, Capecitabine)
Recruiting
- Childhood Solid Tumor
- Vinblastine
- +3 more
-
Brussel, Belgium
- +10 more
May 27, 2022
Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)
Terminated
- Hodgkin Lymphoma
- Rituximab
- Involved field irradiation
-
Houston, Texas
- +10 more
Aug 18, 2021
Breast Cancer Trial in Ottawa (INT230-6, Saline injection)
Recruiting
- Breast Cancer
- INT230-6
- Saline injection
-
Ottawa, Ontario, CanadaThe Ottawa Hospital Research Institute and Cancer Center
Nov 9, 2021
Lymphoma Trial in Giessen (drug, other, procedure)
Active, not recruiting
- Lymphoma
- cyclophosphamide
- +4 more
-
Giessen, GermanyUniversitaetsklinikum Giessen-Marburg
May 10, 2021
Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States
Recruiting
- Recurrent Low Grade Astrocytoma
- +4 more
- Quality-of-Life Assessment
- +3 more
-
Birmingham, Alabama
- +64 more
Aug 20, 2022
Progressive Desmoids Tumors Trial in Bordeaux (PAZOPANIB treatment, Active Comparator: Vinblastine and Methotrexate)
Completed
- Progressive Desmoids Tumors
- PAZOPANIB treatment
- Active Comparator: Vinblastine and Methotrexate
-
Bordeaux, Aquitaine, FranceInstitut Bergonié
Feb 15, 2021
Hodgkin Lymphoma Trial in United Kingdom (Involved site radiotherapy, Doxorubicin, Bleomycin)
Recruiting
- Hodgkin Lymphoma
- Involved site radiotherapy
- +6 more
-
Aberdeen, United Kingdom
- +6 more
May 24, 2022
Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma Trial in San Diego,
Completed
- Recurrent B-Cell Childhood Acute Lymphoblastic Leukemia
- Recurrent Childhood B-Lymphoblastic Lymphoma
- dexamethasone
- +18 more
-
San Diego, California
- +2 more
Sep 13, 2022
HIV, Hodgkin's Disease Trial in United States (Vinblastine sulfate, Dacarbazine, Filgrastim)
Completed
- HIV Infections
- Hodgkin's Disease
- Vinblastine sulfate
- +4 more
-
Birmingham, Alabama
- +7 more
Oct 26, 2021
Brain and CNS Tumors Trial in Australia, United States (Induction Chemotherapy, Low-Risk Therapy, High-Risk Therapy)
Active, not recruiting
- Brain and Central Nervous System Tumors
- Induction Chemotherapy
- +3 more
-
Palo Alto, California
- +5 more
Nov 29, 2022
Infiltrating Urothelial Carcinoma, KRAS Gene Mutation Trial in France (Chemotherapy, Panitumumab)
Completed
- Infiltrating Urothelial Carcinoma
- KRAS Gene Mutation
-
Bordeaux, France
- +16 more
Mar 4, 2021
Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8, Muscle Invasive Bladder Carcinoma Trial in Seattle (drug,
Recruiting
- Stage II Bladder Cancer AJCC v8
- +2 more
- Cisplatin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 16, 2022